Psychedelics
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
101
NCT05397041
A 3-Part Study to Evaluate the Safety, Tolerability, PK, and Food Effect of BMB-101 in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 6, 2022
Completion: May 4, 2023
NCT06401538
BMB-101 in Absence Epilepsy and DEE
Phase: Phase 2
Start: Dec 5, 2024
Completion: Nov 30, 2025